|
2022
|
Invention
|
Recombinant nucleic acid construct encoding influenza peptides and compositions.
The present spe... |
|
2021
|
Invention
|
Chagas antigens and antibodies and compositions, methods and uses thereof.
The present specifica... |
|
2020
|
Invention
|
Influenza peptides and compositions. The present specification discloses recombinant nucleic acid... |
|
2019
|
Invention
|
Influenza peptides and compositions.
The present specification discloses recombinant nucleic aci... |
|
2018
|
Invention
|
Peptide sequences and compositions. The present specification discloses recombinant nucleic acid ... |
|
2017
|
Invention
|
Hiv and immunogenic peptide sequences and compositions. The present specification discloses an im... |
|
|
Invention
|
Chagas antigens and antibodies and compositions, methods and uses thereof. The present specificat... |
|
|
Invention
|
Chagas antigens and antibodies and compositions, methods and uses thereof. Trypanosoma-based dise... |
|
2016
|
Invention
|
Peptide sequences and compositions. Provided is a polypeptide having no more than 100 amino acids... |
|
2015
|
Invention
|
Hiv peptides and immunogenic compositions. The present specification discloses an immunogenic com... |
|
2014
|
Invention
|
Hiv antigens and antibodies and compositions, methods and uses thereof. The present specification... |
|
|
Invention
|
Hiv antigens and antibodies and compositions, uses and methods thereof. The present specification... |
|
2012
|
Invention
|
Peptide sequences of hiv polypeptides and compositions thereof. The present specification disclos... |
|
2011
|
P/S
|
Pharmaceuticals, veterinary preparations, dietetic
substances for medical use; plasters, disinfe... |
|
2010
|
Invention
|
Pharmaceutical agent.
Provided is a pharmaceutical agent for use in the treatment of inflammatio... |
|
|
Invention
|
Pharmaceutical agent. Provided is a pharmaceutical agent for use in the treatment of inflammation... |
|
|
Invention
|
Peptide sequences and compositions. from polypeptide sequences having 85% homology or more with o... |
|
|
Invention
|
Pharmaceutical agent. Provided is a pharmaceutical agent comprising a pharmaceutically active moi... |
|
2008
|
Invention
|
Pharmaceutical compound. Provided is a compound comprising: (a) a first component capable of bind... |
|
|
Invention
|
Peptide sequences and compositions. Provided is a polypeptide composition comprising one or more ... |
|
2007
|
Invention
|
Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof. Pr... |
|
|
Invention
|
Peptide sequences and compositions. Provided is a polypeptide having no' more than 100 amino... |
